Skip to main content

Aino Health AB (publ): Aino Health interim report January-September 2021

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.

Continued focus on Swedish market, Systematic investment in sales and marketing continues

January – September 2021

  • Net sales were KSEK 17,543 (17,784) 
  • Profit/loss after financial items was KSEK -11,368 (-10,518) 
  • Earnings per share were SEK -0.4 (-0.7)

The project that Aino has had with the municipality of Botkyrka since 2018 ended, in accordance with the contract, during the third quarter of this year, and the project results are now being evaluated by the governmental research institute RISE. From Aino’s perspective, it has been clear during the project period that the project has been very positive and has led to decreased sick leave within the municipality.

Aino will also evaluate the project from its perspective, to see how lessons learned can be applied to other public organizations, to contribute toward decreased sick leave and healthier employees. 

During the quarter, Aino has become a member of the sustainability platform CSR Sweden.
This gives Aino continued possibilities to conduct its CSR work together with other Swedish companies and creates increased opportunities to influence and create sustainability in Swedish professional life.

SaaS subscriptions 

As of September 30, Aino Health has around 52,000 subscribers. The main part of the net change in the number of subscribers is because the three-year contract with the municipality of Botkyrka ended, in accordance with the agreement. At the end of september, the number of licenses is around 52,000, as Aino has managed to sign around 8,000 new licenses during the month. 

The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on October 29, 2021.

For more information:

Jyrki Eklund,
CEO Aino Health,
Phone: +358 40 042 4221

Certified adviser
Erik Penser Bank
+46 8 463 83 00
certifiedadviser@penser.se

About Aino Health (publ)

Aino Health is the leading supplier of Software as a Service solutions in Corporate Health Management. The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs, and improves business results through increased productivity and employee engagement by making health, wellbeing, and safety an integrated part of everyday work. For more information visit ainohealth.com. Aino Health AB (publ) is listed on Nasdaq First North Growth Market (Ticker: AINO).
For more information: https://investors.ainohealth.com/en.

Attachments

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.